Some people get into their line of work “by accident,” but in Peter Blumenthal’s case, he really did suffer a life-threatening accident that eventually got him to buy Theracycle. He spoke with Chief Executive about it and how he found the company’s niche market.
Highlights from a recent speech by Jeff Bezos at an event hosted The Economic Club of Washington DC. In the speech, Bezos hit on a variety of topics, including telling the audience that he’d soon announce the location of Amazon’s second headquarters.
A recent interview shares insights into how Jeff Bezos thinks about strategy and innovation, and structures his personal activities and those of the company to get done what he wants to get done. Here are five useful takeaways.
School is back in session, not just for students—but for CEOs too. Here are seven ways you can improve innovation at your company by partnering with a research university.
Zoë Barry, 32-year-old CEO of ZappRX, is going after a $300 billion market that she says “floats on the back of fax machines.” She speaks with Chief Executive about Amazon’s foray into healthcare, the industry’s innovation problem and the challenges of being a young CEO.
CEOs often talk about the strategic imperative for their organizations to boost innovation across the entire enterprise—but few actually succeed in reaching everyone. The CEO of Saint-Gobain North America shares his three step process to achieving a culture of innovation.
Dogs aren’t just a man’s best friend. For Embark CEO Ryan Boyko, they’re a culmination of a career in science and DNA. Boyko talked with Chief Executive about the potential business opportunities in dog DNA and how he transitioned from a career in science to running a business.
Want a crash course in coping with technology-driven change? Learn from the master and serial disruptor Dean Kamen.
Passionate, poised and relentlessly methodical, Lockheed Martin’s Marillyn Hewson has proved to be the right leader for risky times. And now she’s Chief Executive’s 2018 CEO of the Year.
Dr. Cedric Francois co-founded Apellis Pharmaceuticals in 2009 and has managed the company through an impressive period of growth, taking the company public last year.